U.S. Markets close in 4 hrs 34 mins

Recent Analysis Shows Brown Forman, CryoLife, Aspen Group, Taylor Devices, Synergy Pharmaceuticals, and Ramco-Gershenson Properties Trust Market Influences — Renewed Outlook, Key Drivers of Growth

NEW YORK, Nov. 13, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Brown Forman Corporation (BF-A), CryoLife, Inc. (CRY), Aspen Group Inc. (ASPU), Taylor Devices, Inc. (TAYD), Synergy Pharmaceuticals, Inc. (SGYP), and Ramco-Gershenson Properties Trust (RPT), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

BF.A DOWNLOAD: http://MarketSourceResearch.com/register/?so=BF.A
CRY DOWNLOAD: http://MarketSourceResearch.com/register/?so=CRY
ASPU DOWNLOAD: http://MarketSourceResearch.com/register/?so=ASPU
TAYD DOWNLOAD: http://MarketSourceResearch.com/register/?so=TAYD
SGYP DOWNLOAD: http://MarketSourceResearch.com/register/?so=SGYP
RPT DOWNLOAD: http://MarketSourceResearch.com/register/?so=RPT

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Market Source Research, available for free download at the links above, examine Brown Forman Corporation (BF-A), CryoLife, Inc. (CRY), Aspen Group Inc. (ASPU), Taylor Devices, Inc. (TAYD), Synergy Pharmaceuticals, Inc. (SGYP), and Ramco-Gershenson Properties Trust (RPT) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed November 9th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

BROWN FORMAN CORPORATION (BF.A) REPORT OVERVIEW

Brown Forman's Recent Financial Performance

For the three months ended July 31st, 2018 vs July 31st, 2017, Brown Forman reported revenue of $766.00MM vs $723.00MM (up 5.95%) and analysts estimated basic earnings per share $0.42 vs $0.37 (up 13.51%). For the twelve months ended April 30th, 2018 vs April 30th, 2017, Brown Forman reported revenue of $3,248.00MM vs $2,994.00MM (up 8.48%) and analysts estimated basic earnings per share $1.49 vs $1.38 (up 7.97%). Analysts expect earnings to be released on December 5th, 2018. The report will be for the fiscal period ending October 31st, 2018. The reported EPS for the same quarter last year was $0.50.

To read the full Brown Forman Corporation (BF.A) report, download it here: http://MarketSourceResearch.com/register/?so=BF.A

-----------------------------------------

CRYOLIFE, INC. (CRY) REPORT OVERVIEW

CryoLife's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, CryoLife reported revenue of $64.60MM vs $44.00MM (up 46.82%) and analysts estimated basic earnings per share $0.04 vs $0.04 (unchanged). For the twelve months ended December 31st, 2017 vs December 31st, 2016, CryoLife reported revenue of $189.70MM vs $180.38MM (up 5.17%) and analysts estimated basic earnings per share $0.11 vs $0.33 (down 66.67%). Analysts expect earnings to be released on March 6th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was $0.11. The estimated EPS forecast for the next fiscal year is $0.53 and is expected to report on March 6th, 2019.

To read the full CryoLife, Inc. (CRY) report, download it here: http://MarketSourceResearch.com/register/?so=CRY

-----------------------------------------

ASPEN GROUP INC. (ASPU) REPORT OVERVIEW

Aspen Group's Recent Financial Performance

For the three months ended July 31st, 2018 vs July 31st, 2017, Aspen Group reported revenue of $7.22MM vs $4.24MM (up 70.20%) and analysts estimated basic earnings per share -$0.15 vs -$0.06. For the twelve months ended April 30th, 2018 vs April 30th, 2017, Aspen Group reported revenue of $22.02MM vs $14.25MM (up 54.57%) and analysts estimated basic earnings per share -$0.50 vs -$0.10. Analysts expect earnings to be released on December 12th, 2018. The report will be for the fiscal period ending October 31st, 2018. Reported EPS for the same quarter last year was -$0.04. The estimated EPS forecast for the next fiscal year is $0.01 and is expected to report on July 11th, 2019.

To read the full Aspen Group Inc. (ASPU) report, download it here: http://MarketSourceResearch.com/register/?so=ASPU

-----------------------------------------

TAYLOR DEVICES, INC. (TAYD) REPORT OVERVIEW

Taylor Devices' Recent Financial Performance

For the three months ended August 31st, 2018 vs August 31st, 2017, Taylor Devices reported revenue of $7.31MM vs $6.57MM (up 11.36%) and basic earnings per share $0.21 vs $0.09 (up 133.33%). For the twelve months ended May 31st, 2018 vs May 31st, 2017, Taylor Devices reported revenue of $24.36MM vs $25.54MM (down 4.59%) and analysts estimated basic earnings per share $0.13 vs $0.68 (down 80.88%). Analysts expect earnings to be released on January 11th, 2019. The report will be for the fiscal period ending November 30th, 2018.

To read the full Taylor Devices, Inc. (TAYD) report, download it here: http://MarketSourceResearch.com/register/?so=TAYD

-----------------------------------------

SYNERGY PHARMACEUTICALS, INC. (SGYP) REPORT OVERVIEW

Synergy Pharmaceuticals' Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Synergy Pharmaceuticals reported revenue of $12.25MM vs $2.31MM (up 429.56%) and analysts estimated basic earnings per share -$0.12 vs -$0.33. Analysts expect earnings to be released on March 7th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was -$0.18. The estimated EPS forecast for the next fiscal year is -$0.22 and is expected to report on March 7th, 2019.

To read the full Synergy Pharmaceuticals, Inc. (SGYP) report, download it here: http://MarketSourceResearch.com/register/?so=SGYP

-----------------------------------------

RAMCO-GERSHENSON PROPERTIES TRUST (RPT) REPORT OVERVIEW

Ramco-Gershenson Properties Trust's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Ramco-Gershenson Properties Trust reported revenue of $64.22MM vs $65.93MM (down 2.60%) and analysts estimated basic earnings per share $0.10 vs $0.34 (down 70.59%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Ramco-Gershenson Properties Trust reported revenue of $265.08MM vs $260.93MM (up 1.59%) and analysts estimated basic earnings per share $0.78 vs $0.66 (up 18.18%). Analysts expect earnings to be released on February 19th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.31. The estimated EPS forecast for the next fiscal year is $1.31 and is expected to report on February 19th, 2019.

To read the full Ramco-Gershenson Properties Trust (RPT) report, download it here: http://MarketSourceResearch.com/register/?so=RPT

-----------------------------------------

ABOUT MARKET SOURCE RESEARCH

Market Source Research delivers the key research reports that helps serious investors, registered brokers, professional traders, and personal investment advisers find reliable information in today's markets. Market Source Research's team is comprised of financial professionals, many of which hold Chartered Financial Analyst® (CFA®) designations and FINRA® BrokerCheck® certifications. Whether identifying emerging trends, or discovering new opportunity, the team at Market Source Research is dedicated to providing accurate, informative, and objective content that's ahead of the curve. With insights on individual companies as well as sectors, readers get the industry's best available combination of big-picture perspective as well as granular detail.

REGISTERED MEMBER STATUS

Market Source Research's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Market Source Research's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Market Source Research have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Market Source Research's Compliance department by Phone, at +1 (704) 343-6361, or by E-mail at compliance@MarketSourceResearch.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Market Source Research, Market Source Research members, and/or Market Source Research affiliates are not responsible for any gains or losses that result from the opinions expressed. Market Source Research makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Market Source Research has not been compensated for the publication of this press release by any of the above mentioned companies. Market Source Research is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Hugo Moreau, Media Department
Office: +1 (704) 343-6361
E-mail: media@MarketSourceResearch.com

© 2018 Market Source Research. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@MarketSourceResearch.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.